Drug Discovery & Pharma AI

AI platforms that support drug target identification and candidate design.

These vendors apply AI and machine learning to pharmaceutical research and development, including drug target identification, candidate design, and clinical trial support.

Vendors (3)

Sort the comparison by vendor or verification date. Product scope and regulatory status can change, so confirm the exact module, intended use, version, and deployment terms with the vendor and the applicable regulator.
Insilico Medicine Target discovery, molecular design, and clinical development Pharma.AI platform and drug discovery pipeline Platform use is generally upstream of a specific drug regulatory review; verify claims at program and product level Target validation, reproducibility, prospective program milestones, molecule progression, and partner or peer-reviewed results Research data, knowledge graphs, omics, chemistry, laboratory, and portfolio systems as applicable Enterprise research platform, data collaboration, or program partnership; confirm hosting, access, and intellectual property terms 2026-09-26
Recursion Phenotypic data, biological mapping, and drug discovery Recursion OS and technology-enabled drug discovery programs Platform use is generally upstream of a specific drug regulatory review; verify claims at program and product level Target validation, reproducibility, prospective program milestones, molecule progression, and partner or peer-reviewed results Research data, knowledge graphs, omics, chemistry, laboratory, and portfolio systems as applicable Enterprise research platform, data collaboration, or program partnership; confirm hosting, access, and intellectual property terms 2026-09-26
BenevolentAI Disease biology, target identification, and drug discovery Benevolent Platform and pipeline-led drug discovery programs Platform use is generally upstream of a specific drug regulatory review; verify claims at program and product level Target validation, reproducibility, prospective program milestones, molecule progression, and partner or peer-reviewed results Research data, knowledge graphs, omics, chemistry, laboratory, and portfolio systems as applicable Enterprise research platform, data collaboration, or program partnership; confirm hosting, access, and intellectual property terms 2026-09-26

Insilico Medicine

AI-driven biotech using generative AI to identify drug targets and design candidates.

Recursion

AI-driven drug discovery company combining large-scale biological experimentation with machine learning.

BenevolentAI

AI drug discovery company applying machine learning to biomedical data.

Vendor listings are informational and may include sponsored placements. All listings should be independently evaluated by qualified professionals before clinical adoption. Inclusion in this directory is not a clinical endorsement.